DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
0.7000
+0.0040 (0.57%)
Jun 5, 2025, 4:00 PM - Market closed
DarioHealth Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 28.03 | 27.04 | 20.35 | 27.66 | 20.51 | 7.58 | Upgrade
|
| Revenue Growth (YoY) | 47.20% | 32.86% | -26.41% | 34.82% | 170.76% | 0.22% | Upgrade
|
| Cost of Revenue | 8.58 | 8.75 | 9.98 | 13.64 | 12.44 | 5.06 | Upgrade
|
| Gross Profit | 19.46 | 18.3 | 10.37 | 14.01 | 8.07 | 2.51 | Upgrade
|
| Selling, General & Admin | 41.64 | 46.1 | 41.8 | 46.82 | 62.36 | 27.98 | Upgrade
|
| Research & Development | 21.65 | 24.18 | 20.25 | 19.65 | 17.22 | 4.43 | Upgrade
|
| Operating Expenses | 68.03 | 75.31 | 66.43 | 70.82 | 82.54 | 32.42 | Upgrade
|
| Operating Income | -48.57 | -57.02 | -56.06 | -56.81 | -74.47 | -29.9 | Upgrade
|
| Interest Expense | - | - | -0.53 | -2.6 | - | - | Upgrade
|
| Interest & Investment Income | 1.02 | 1.12 | 1.87 | 0.51 | 0.04 | 0.06 | Upgrade
|
| Currency Exchange Gain (Loss) | 0 | -0 | -0.21 | 0.24 | -0.2 | 0.45 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.65 | 12.03 | -4.34 | -3.53 | -0.08 | -0.05 | Upgrade
|
| EBT Excluding Unusual Items | -43.91 | -43.87 | -59.27 | -62.19 | -74.71 | -29.45 | Upgrade
|
| Merger & Restructuring Charges | -0.73 | -0.73 | -0.13 | - | -2.02 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 0.04 | - | - | - | Upgrade
|
| Pretax Income | -44.64 | -44.6 | -59.36 | -62.19 | -76.73 | -29.45 | Upgrade
|
| Income Tax Expense | 0.16 | -1.85 | 0.06 | 0 | 0.03 | - | Upgrade
|
| Net Income | -44.8 | -42.75 | -59.43 | -62.19 | -76.76 | -29.45 | Upgrade
|
| Preferred Dividends & Other Adjustments | -14.83 | -12.66 | -4.57 | -2.24 | -9.24 | 3.66 | Upgrade
|
| Net Income to Common | -29.97 | -30.09 | -54.86 | -59.96 | -67.52 | -33.1 | Upgrade
|
| Shares Outstanding (Basic) | 52 | 49 | 28 | 24 | 17 | 6 | Upgrade
|
| Shares Outstanding (Diluted) | 52 | 49 | 28 | 24 | 17 | 6 | Upgrade
|
| Shares Change (YoY) | 73.72% | 72.84% | 20.04% | 42.45% | 178.23% | 163.15% | Upgrade
|
| EPS (Basic) | -0.57 | -0.61 | -1.93 | -2.54 | -4.07 | -5.55 | Upgrade
|
| EPS (Diluted) | -0.57 | -0.61 | -1.93 | -2.54 | -4.07 | -5.55 | Upgrade
|
| Free Cash Flow | -32.24 | -38.7 | -30.96 | -48.29 | -50.67 | -17.85 | Upgrade
|
| Free Cash Flow Per Share | -0.62 | -0.79 | -1.09 | -2.04 | -3.05 | -2.99 | Upgrade
|
| Gross Margin | 69.41% | 67.66% | 50.95% | 50.67% | 39.34% | 33.17% | Upgrade
|
| Operating Margin | -173.25% | -210.85% | -275.46% | -205.42% | -363.06% | -394.71% | Upgrade
|
| Profit Margin | -106.90% | -111.28% | -269.56% | -216.80% | -329.16% | -436.95% | Upgrade
|
| Free Cash Flow Margin | -115.00% | -143.12% | -152.14% | -174.60% | -247.01% | -235.67% | Upgrade
|
| EBITDA | -41.21 | -49.59 | -51.08 | -52.09 | -70.02 | -29.71 | Upgrade
|
| EBITDA Margin | -147.01% | -183.39% | -250.96% | -188.36% | - | - | Upgrade
|
| D&A For EBITDA | 7.36 | 7.43 | 4.99 | 4.72 | 4.46 | 0.19 | Upgrade
|
| EBIT | -48.57 | -57.02 | -56.06 | -56.81 | -74.47 | -29.9 | Upgrade
|
| EBIT Margin | -173.25% | -210.85% | -275.46% | -205.42% | - | - | Upgrade
|
| Revenue as Reported | 28.03 | 27.04 | 20.35 | 27.66 | 20.51 | - | Upgrade
|
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.